Jonathan Lovell

PhD

UB Distinguished Professor

Nanomedicine; phototherapy

Buffalo NY, 14260

Phone: (716) 645-1020

Fax: (716) 645-2207

New protein vaccine approach could enable faster responses to Disease X
7/23/25
The Coalition for Epidemic Preparedness Innovations (CEPI) reported that it will provide POP Biotechnologies, a UB startup co-founded by Jonathan Lovell), with $1.5 million for research into making vaccines against epidemic and pandemic threats.
Researchers at the University at Buffalo are working on light-infused treatment
6/20/25
WIVB featured an interview with Jonathan Lovell for his research into a smarter and more effective way to deliver chemotherapy in metastatic pancreatic cancer using light-infused treatment.
Three SEAS faculty receive SUNY Chancellor’s Awards
6/6/25
Paschalis Alexandridis, Jonathan Lovell and Filip Stefanovic have received SUNY Chancellor’s Awards, recognizing their consistently superior professional achievements and ongoing pursuit of excellence.
UB scientists working on bird flu vaccine
4/28/25
WBEN reported that UB scientists, led by Jonathan Lovell, are working on a potential new vaccine to combat bird flu that might be easier to produce than egg-based vaccines.
Study: Experimental bird flu vaccine excels in animal models
4/17/25
A vaccine under development at UB, led by Jonathan Lovell, has demonstrated complete protection in mice for a deadly variant of the virus that causes bird flu.